Table 1.

Clinical information for primary pancreatic samples

		Pancreas Primary Tumors
	Normal (N=4)	PanINs (N=20)	Stage I (N=38)	Stage II (N=78)	Stage III (N=5)	Stage IV (N=2)
Median Survival (months)		137.3	42.4	17.8	13.9	19.6
Gender
Male	3 (75%)	9 (45%)	9 (23.7%)	44 (57%)	1 (20%)	2 (100%)
Female	1 (25%)	11 (55%)	29 (76.3%)	34 (43%)	4 (80%)	0.0%
Grade
Well Differentiated		9 (45%)	3 (7.9%)	4 (5.1%)	1 (20%)	0 (0%)
Moderately Differentiated		8 (40%)	23 (60.5%)	41 (52%)	4 (40%)	1 (50%)
Poorly Differentiated		3 (15%)	12 (31.6%)	33 (42.9%)	4 (40%)	1 (50%)